Skip to main content
. 2020 May 12;14(10):330–336. doi: 10.5489/cuaj.6440

Supplementary Table 2.

Specific sources of potential bias in randomized adjuvant radiation trials

Feature predisposing to bias Inclusion of patients with postoperatively detectable PSA Low rates of salvage treatment in control arms Very late use of salvage radiation (PSA >1.0 ng/ml)
 SWOG-8794 Yes Yes Yes
 EORTC-22911 Yes Yes Yes
 ARO-96-02 No Unknown Unknown
 FinnProstate Yes No No

PSA: prostate-specific antigen.